首页> 外文期刊>Transplantation Proceedings >No-touch en bloc right lobe living-donor liver transplantation with inferior vena cava replacement for hepatocellular carcinoma close to retrohepatic inferior vena cava: Case report
【24h】

No-touch en bloc right lobe living-donor liver transplantation with inferior vena cava replacement for hepatocellular carcinoma close to retrohepatic inferior vena cava: Case report

机译:非接触式整块右叶活体供肝肝移植与下腔静脉置换治疗接近肝后下腔静脉的肝细胞癌:病例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Current studies have shown that living-donor liver transplantation (LDLT) for hepatocelluar carcinoma (HCC) satisfying the Milan criteria does not compromise patient survival or increase HCC recurrence compared with deceased-donor liver transplantation (DDLT). For patients with HCC beyond the Milan criteria, however, worse outcomes are expected after LDLT than after DDLT, despite insufficient data to reach a conclusion. Regarding operative technique, LDLT might be a less optimal cancer operation for HCC located at the hepatic vein confluence and/or paracaval portion. The closeness to the wall of the retrohepatic inferior vena cava (IVC) is greater than in conventional DDLT, rendering it difficult to perform a no-touch en bloc total hepatectomy. An LDLT, which must preserve the native IVC for the piggyback technique during engraftment, may lead to tumor remnants. To reduce recurrences after LDLT, we successfully performed a no-touch en bloc total hepatectomy including the retrohepatic IVC and all 3 hepatic veins. IVC replacement with an artificial vascular graft together with a modified right-lobe LDLT was performed for a patient having advanced HCC close to the hepatic vein confluence and paracaval portion. There was no artificial vascular graft-related complication, such as thrombosis or infection. Despite the limitations of LDLT, requiring the piggyback technique for graft implantation, IVC replacement using an artificial graft led us to perform a no-touch en bloc total hepatectomy as with a conventional DDLT.
机译:当前研究表明,与死者肝移植(DDLT)相比,满足米兰标准的肝细胞癌(HCC)活体肝移植(LDLT)不会损害患者的存活率或增加HCC复发。然而,对于肝癌超出米兰标准的患者,尽管数据不足以得出结论,但预计LDLT后的结果要比DDLT后的结果差。对于手术技术,LDLT对于位于肝静脉汇合处和/或腔旁部位的HCC可能不是最佳的癌症手术方法。与常规DDLT相比,肝后下腔静脉(IVC)与壁的紧密度更大,因此难以进行全接触式全肝切除术。 LDLT必须在植入过程中保留本机IVC以用于搭载技术,否则可能会导致肿瘤残留。为了减少LDLT后的复发,我们成功地进行了全肝非接触式全肝切除术,包括肝后IVC和所有3条肝静脉。对于晚期HCC接近肝静脉汇合处和腔旁部分的患者,用人工血管移植物和改良的右叶LDLT进行IVC置换。没有人工血管移植相关的并发症,例如血栓形成或感染。尽管LDLT有局限性,需要背负式技术进行移植物植入,但使用人工移植物替代IVC仍使我们能够像常规DDLT一样进行全接触式全肝切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号